P165: Vitamin D deficiency is associated with poor sleep quality in patients with Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Walker, C.(1)*;Stacey, W.(1);Ramkalawan, K.M.(1);Kafienah, Y.(1);Connaughton, R.(1);Breslin, N.(1);McNamara, D.(1);O'Donnell, S.(1);Ryan, B.(1);O'Connor, A.(1);
(1)Tallaght University Hospital, Gastroenterology Department, Dublin 24, Ireland;
P166: Calprotectin in patients with perianal fistula: the CANALS studyECCO’23 CopenhagenYear: 2023
Authors: Beckerdrs., M.(1)*;Stevens, T.(2);de Voogd, F.(2);Wildenberg, M.(1);Gecse, K.(2);Buskens, C.(3);
(1)Tytgat Institute for Liver and Intestinal Research, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(3)Amsterdam UMC, Surgery, Amsterdam, The Netherlands;
P167: Ileocecal valve that cannot be intubated during colonoscopy in patients with Crohn's disease: Is this a sign of poor prognosis?ECCO’23 CopenhagenYear: 2023
Authors: Durak, M.B.(1);Simsek, C.(2);Inan, B.(1);Yuksel, I.(1,3)*;
(1)Ankara City Hospital, Department of Gastroenterology, Ankara, Turkey;(2)Health Sciences University- Mehmet Akif Inan Training and Research Hospital, Depatment of Gastroenterology, Sanliurfa, Turkey;(3)Ankara Yildirim Beyazit University School of Medicine, Department of Gastroenterology, Ankara, Turkey;
P169: Copy number variation of alpha defensin 1-3 is a predictive marker of therapeutic response in ulcerative colitisECCO’23 CopenhagenYear: 2023
Authors: Kanmura, S.(1)*;Tanaka, A.(1);Maeda, N.(1);Kuwazuru, K.(2);Komaki, F.(1);Sameshima, Y.(3);Komaki, Y.(1);Ido, A.(1);
(1)Kagoshima University Graduate School of Medical and Dental Sciences, Digestive and Lifestyle Diseases, Kagoshima, Japan;(2)Kagoshima University Graduate School of Medical and Dental Sciences, Digestive and Lifestyle Diseases, Kagosima, Japan;(3)Imamura general hospital, Department of Gastroenterology, Kagoshima, Japan;
P170: Can histological activity of ulcerative colitis be predicted by assessment of the rectosigmoid colon?ECCO’23 CopenhagenYear: 2023
Authors: Temido, M.J.(1)*;Gama, J.(2);Caetano Oliveira, R.(2);Silva, A.(1);Lopes, S.(1);Mendes, S.(1);Ferreira, M.(1);Ferreira, M.(1);Narra Figueiredo, P.(1);Portela, F.(1);
(1)Centro Hospitalar e Universitário de Coimbra, Gastroenterology, Coimbra, Portugal;(2)Centro Hospitalar e Universitário de Coimbra, Pathology, Coimbra, Portugal;
P171: Subfertility in young patients with Crohn´s disease. A case-control study.ECCO’23 CopenhagenYear: 2023
Authors: Gutiérrez Casbas, A.(1)*;Bernal, L.(2);Zapater, P.(3);Herreros, B.(4);Rodríguez, A.(2);Muñoz, R.(2);Madero, L.(5);Orts, B.(6);Belen, O.(2);Sempere, L.(2);Torregrosa, M.E.(7);Moreno-Pérez, O.(8);Francés, R.(9);
(1)Hospital General Universitario Alicante, Gastroenterology- CIBERehd- Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL, Alicante, Spain;(2)Hospital General Universitario Dr Balmis de Alicante, Gastroenterology, Alicante, Spain;(3)Hospital General Universitario Dr Balmis de Alicante- CIBERehd- Universidad Miguel Hernández Elche- ISABIAL, Clinical Pharmacology, Alicante, Spain;(4)Hospital Marina Baixa- Villajoyosa- Alicante, Gastroenterology, Alicante, Spain;(5)Hospital General Universitario Dr Blamis de Alicante and ISABIAL, Gastroenterology, Alicante, Spain;(6)Hospital General Universitario Dr Balmis de Alicante and ISABIAL, Clinical Pharmacology, Alicante, Spain;(7)Hospital General Universitario Dr Balmis de Alicante, Clinical Biochemestry, Alicante, Spain;(8)Hospital General Universitario Dr Balmis de Alicante and ISABIAL, Endocrinology, Alicante, Spain;(9)Departamento de Medicina Clínica- Universidad Miguel Hernández de Elche- CIBERehd and ISABIAL, Immunology, Alicante, Spain;
P172: Metabolic disorders with non-alcoholic fatty liver disease in people with inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Walker, C.(1)*;Stapleton, E.(1);Dempsey, M.(1);Carroll, A.(1);Connaughton, R.(1);Breslin, N.(1);McNamara, D.(1);O'Donnell, S.(1);Ryan, B.(1);O'Connor, A.(1);
(1)Tallaght University Hospital, Gastroenterology Department, Dublin 24, Ireland;
P173: Patency capsule: A novel independent predictor for long-term outcomes among patients with quiescent Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Ukashi, O.(1,2)*;Kopylov , U.(1,2);Ungar , B.(1,2);Haj-Natour , O.(1,2);Selinger , L.(1,2);Neuman , S.(1,2);Yanai , H.(2,3);Dotan , I.(2,3);Yablecovitch , D.(1,2);Lahat , A.(1,2);Eliakim , R.(1,2);Ben-Horin , S.(1,2);
(1)Sheba Medical Center Tel Hashomer, Gastroenterology Institute, Ramat gan, Israel;(2)Tel-Aviv University, Sackler School of Medicine, Tel Aviv, Israel;(3)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;
P174: Uncontrolled depression and female gender increase the risk of severe fatigue in patients with inflammatory bowel disease under infliximab therapy.ECCO’23 CopenhagenYear: 2023
Authors: Ferreiro Iglesias, R.(1)*;Calvino-Suarez, C.(1);Baston-Rey, I.(1);Mauriz-Barreiro, V.(2);Dominguez-Munoz, J.E.(1);Barreiro-de Acosta, M.(1);
(1)University Hospital Santiago De Compostela CHUS, Department of Gastroenterology- IBD Unit, Santiago De Compostela, Spain;(2)University Hospital Ferrol CHUF, Department of Gastroenterology, Ferrol, Spain;
P175: Burden of Inflammatory Bowel Disease in Mexico: RISE-MX, a Multi-center, Retrospective, 3-Year Data StudyECCO’23 CopenhagenYear: 2023
Authors: Yamamoto-FurushoMD- PhD, J.K.(1)*;Martinez-Vazquez, M.(2);Miranda-Cordero, R.(3);Bosques.Padilla, F.(4);
(1)IBD Clinic- Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico City, Mexico;(2)Tecnologico de Monterrey- Escuela de Medicina y Ciencias de la Salud Monterrey, Gastroenterology, MOnterrey, Mexico;(3)Inflammatory Bowel Disease Clinic- Centro Médico ISSEMyM, Gastroenterology, Toluca, Mexico;(4)Hospital Universitario- Universidad Autónoma de Nuevo León, Gastroenterology, Monterrey, Mexico;RISE-MX Study Group
P176: Clinical features of acute severe ulcerative colitis according to steroid dependency: A KASID multicenter studyECCO’23 CopenhagenYear: 2023
Authors: Kim, D.H.(1)*;Kim, H.S.(2);Kim, E.S.(3);Park, S.H.(4);Kim, S.J.(5);Kim, K.O.(6);Lee, Y.J.(7);Song, E.M.(8);Kim, D.S.(9);
(1)Chonnam National University Hospital, Division of gastroenterology- Department of Internal medicine and Inflammatory Bowel disease Clinic, Gwnagju, Korea- Republic Of;(2)Chonnam National University Hospital, Department of Internal Medicine- Division of Gastroenterology and Clnics of Inflammatory Bowel Disease, Gwangju, Korea- Republic Of;(3)Kyungpook University Hospital, Department of Internal Medicine- Division of Gastroenterology, Daegu, Korea- Republic Of;(4)Asan Medical Center, Department of Internal Medicine- Division of Gastroenterology, Seoul, Korea- Republic Of;(5)Chosun University Hospital, Department of Internal Medicine- Division of Gastroenterology, Gwangju, Korea- Republic Of;(6)Yeungnam University Hospital, Department of Internal Medicine- Division of Gastroenterology, Gwangju, Korea- Republic Of;(7)Keimyung University Hospital, Department of Internal Medicine- Division of Gastroenterology, Daegu, Korea- Republic Of;(8)Ewha Womans University Seoul Hospital, Department of Internal Medicine- Division of Gastroenterology, Seoul, Korea- Republic Of;(9)Konyang University Hospital, Department of Internal Medicine- Division of Gastroenterology, Daejeon, Korea- Republic Of;IBD Research Group in Korean Association for the Study of the Intestinal Diseases (KASID)
P177: C-reactive protein/albumin ratio: a novel biomarker for monitoring of the disease activity in Ulcerative Colitis patientsECCO’23 CopenhagenYear: 2023
Authors: Tomasic, V.(1)*;Biscanin, A.(1,2);Ćaćić, P.(1);Palac, L.(2);Dorosulic, Z.(1);Kralj, D.(1);Babic, F.(1);Ogresta, D.(1);Hrabar, D.(1,2);
(1)Sestre milosrdnice University Hospital Center, Department of Gastroenterology and Hepatology, Zagreb, Croatia;(2)University of Zagreb School od Medicine, Internal medicine, Zagreb, Croatia;
P178: Evaluation of the Ulcerative Colitis Intestinal Ultrasound (UC-IUS) Index in Pediatric patients with newly diagnosed ulcerative colitisECCO’23 CopenhagenYear: 2023
Authors: Hudson, A.(1);Ma, H.(1);Lo, C.(1);Kim, J.(1);Kuc, A.(1);Novak, K.(2);Carroll, M.(1);Wine, E.(1);Isaac, D.(1);HuynhDr, H.(1)*;
(1)University of Alberta, Department of Paediatrics- Division of Gastroenterology and Nutrition, Edmonton, Canada;(2)University of Calgary, Department of Medicine- Division of Gastroenterology and Hepatology, Calgary, Canada;
P179: Comparative benefit-risk profile of induction and maintenance therapy with upadacitinib versus placebo in patients with moderately to severely active ulcerative colitisECCO’23 CopenhagenYear: 2023
Authors: Blumenstein, I.(1)*;Xuan, S.(2);Panaccione, R.(3);Baert, F.(4);Barreiro-de Acosta, M.(5);Ye, B.D.(6);Klaff, J.(2);Vladea, R.(2);Levy, G.(2);Holweg, C.T.J.(2);Sanchez Gonzalez, Y.(2);Dubinsky, M.C.(7);
(1)Goethe University Clinic, n/a, Frankfurt, Germany;(2)AbbVie Inc, n/a, North Chicago, United States;(3)University of Calgary, Department of Gastroenterology and Hepatology, Alberta, Canada;(4)AZ Delta, Department of Gastroenterology, Roeselare, Belgium;(5)University Hospital of Santiago de Compostela, Inflammatory Bowel Disease Unit, Galicia, Spain;(6)Asan Medical Centre- University of Ulsan College of Medicine, Department of Gastroenterology and Inflammatory Bowel Disease Center, Seoul, Korea- Republic Of;(7)Icahn School of Medicine at Mt. Sinai, Susan and Leonard Feinstein IBD Center, New York, United States;
P180: Ileorectal anastomosis preserves female fertility after colectomy in Ulcerative ColitisECCO’23 CopenhagenYear: 2023
Authors: Druvefors, E.(1)*;Myrelid, P.(2);Andersson, R.E.(1);Landerholm, K.(1);
(1)Department of Surgery- County Hospital Ryhov- Jönköping- Sweden, Department of Biomedical and Clinical Sciences- Faculty of Health Sciences- Linköping University- Linköping- Sweden, Jönköping, Sweden;(2)Department of Surgery- Linköping University Hospital- Linköping- Sweden, Department of Biomedical and Clinical Sciences- Faculty of Health Sciences- Linköping University- Linköping- Sweden, Linköping, Sweden;
P181: infliximab exposure during induction associate with time to remission and disease control of inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Laharie, D.(1)*; Rabizadeh, S.(2);D'Haens, G.(3);Dubinsky, M.(4);Panetta, J.C.(5);Everts-van der Wind, A.(6);Dreesen, E.(7);Spencer, E.(4);Vermeire, S.(8);Dervieux, T.(6);
(1)Hospital Haut-Leveque, Department of Gastroenterology and Hepatology, Pessac, France;(2)Cedars Sinai Medical Center, Gastroenterology, Los Angeles- CA, United States;(3)University of Amsterdam- AMC, Gastroenterology, Amsterdam, The Netherlands;(4)Mount Sinai Medical Center, Gastroenterology, New York- NY, United States;(5)St Jude Children's Research Hospital, Gastroenterology, Memphis TN-, United States;(6)Prometheus, Laboratories, San Diego- CA, United States;(7)KU Leuven, Biology, Leuven, Belgium;(8)KU Leuven, Gastroenterology, Leuven, Belgium;
P182: Modified Multiplier SES-CD (MM-SES-CD) and laboratorial Crohn's disease activity parameters: is there any association?ECCO’23 CopenhagenYear: 2023
Authors: Capela, T.(1,2,3)*;Ferreira, A.I.(1,2,3);Macedo Silva, V.(1,2,3);Freitas, M.(1,2,3);Arieira, C.(1,2,3);Cúrdia Gonçalves, T.(1,2,3);Dias de Castro, F.(1,2,3);Moreira, M.J.(1,2,3);Cotter, J.(1,2,3);
(1)Hospital Senhora da Oliveira, Gastroenterology Department, Guimarães, Portugal;(2)ICVS/3B's- PT Government Associate Laboratory, Gastroenterology, Guimarães/Braga, Portugal;(3)Life and Health Sciences Research Institute ICVS, School of Medicine- University of Minho, Braga/Guimarães, Portugal;
P183: Development of a new simple ultrasound activity score for intestinal Behçet's DiseaseECCO’23 CopenhagenYear: 2023
Authors: Yaguchi, K.(1,2)*;Kunisaki, R.(1,2);Sato, S.(3);Izumi, M.(3);Fukuno, Y.(3);Ebina, T.(3);Matsune, Y.(1);Hama, T.(1);Onishi, M.(1);Kobayashi, K.(1);Shibui, S.(1);Toritani, K.(1);Nishida, D.(1);Matsubayashi, M.(1);Nakamori, Y.(1);Nishio, M.(1);Umezawa, S.(1);Ogashiwa, T.(1);Sasaki, T.(1);Fujii, A.(1);Kimura, H.(1);Numata, K.(2,4);Maeda, S.(2);
(1)Yokohama City University Medical Centre, Inflammatory Bowel Disease Centre, Yokohama, Japan;(2)Yokohama City University Graduate School of Medicine, Department of Gastroenterology, Yokohama, Japan;(3)Yokohama City University Medical Centre, Department of Laboratory Medicine and Clinical Investigation, Yokohama, Japan;(4)Yokohama City University Medical Centre, Gastroenterological Centre, Yokohama, Japan;
P184: Identification of the PAI-1, as a potential non-invasive, fecal biomarker in the Inflammatory Bowel DiseasesECCO’23 CopenhagenYear: 2023
Authors: Jójárt, B.(1)*;Molnár, T.(2);Diána, K.(3);Szabó, V.(4);Varga, Á.(4);Resál, T.(5);Bacsúr, P.(5);Szántó, K.(5);Földesi, I.(3);Molnár, T.(5);Maléth, J.(1);Farkas, K.(5);
(1)University of Szeged, Szent-Györgyi Albert Medical School- Department of Medicine- HAS-USz Momentum Epithelial Cell Signaling and Secretion Research Group- HCEMM-USz Molecular Gastroenterology Research Group- EpiPharma Ltd, Szeged, Hungary;(2)University of Szeged, Szent-Györgyi Albert Medical School- Department of Medicine- HAS-USz Momentum Epithelial Cell Signaling and Secretion Research Group, Szeged, Hungary;(3)University of Szeged, Szent-Györgyi Albert Medical School- Institute of Laboratory Medicine, Szeged, Hungary;(4)University of Szeged, Szent-Györgyi Albert Medical School- Department of Medicine- HAS-USz Momentum Epithelial Cell Signaling and Secretion Research Group- HCEMM-USz Molecular Gastroenterology Research Group, Szeged, Hungary;(5)University of Szeged, Szent-Györgyi Albert Medical School- Department of Medicine, Szeged, Hungary;HAS-USz Momentum Epithelial Cell Signaling and Secretion Research Group
